Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408680 · ClinicalTrials.gov registry record · NA
CoQ10 Biomarker Trial
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01408680 is a NA study that has completed, run by University of Washington. The registered enrollment target is 66 participants.
The verdict
NCT01408680, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The investigators believe that relieving the oxidative stress experienced by hemodialysis patients may help improve cardiovascular health. In this study, the investigators hypothesize that administration of coenzyme Q10, as a targeted antioxidant therapy, will ameliorate the excessive oxidative stress experienced by hemodialysis patients. This will lead to improvements in biomarkers of: * oxidative stress status * inflammatory status * endothelial dysfunction
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408680
The ClinicalTrials.gov registry entry for NCT01408680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01408680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01408680 about?
NCT01408680 is a clinical study titled "CoQ10 Biomarker Trial". The investigators believe that relieving the oxidative stress experienced by hemodialysis patients may help improve cardiovascular health. In this study, the investigators hypothesize that administration of coenzyme Q10, as a targeted antioxidant therapy, will ameliorate the excessive oxidative str...
What is the current status of trial NCT01408680?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2011-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01408680?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Coenzyme Q10 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01408680?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.